RxDoctor Payments Data

Robert Nordman, PA

Physician Assistant · Cottonwood, AZNPI 1891783338

Payments from drug & device makers

$6,891in general payments, 2019–2025

Across 318 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$829
  • Otsuka America Pharmaceutical, Inc.$665
  • Neurocrine Biosciences, Inc.$507
  • Takeda Pharmaceuticals U.S.A., Inc.$469
  • Alkermes, Inc.$451
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$6,81799%
  • Education$741%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,891 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$149,599
Medicare patients
283
Services billed
1,721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$114,391
VraylarCariprazine Hcl24$53,850
Invega SustennaPaliperidone Palmitate22$53,365
CaplytaLumateperone Tosylate24$51,115
RexultiBrexpiprazole12$48,065
Lurasidone Hcl78$29,449
BelsomraSuvorexant58$24,252
Aripiprazole241$14,047
TrintellixVortioxetine Hydrobromide11$13,754
Ziprasidone Hcl50$10,504
Quetiapine Fumarate278$6,837
Duloxetine Hcl228$6,494
Lamotrigine362$5,941
Divalproex Sodium ErDivalproex Sodium77$5,834
Bupropion XlBupropion Hcl166$5,278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$829$114,39112 claims
AbbVieVraylar$1,932$53,85024 claims
Johnson & JohnsonInvega Sustenna$41$53,36522 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$332$51,11524 claims
Otsuka America Pharmaceutical, Inc.Rexulti$665$48,06512 claims
MerckBelsomra$99$24,25258 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$469$13,75411 claims
Almatica Pharma LLCSertraline Hcl$84$1,532154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Cottonwood

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →